Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02DLL
|
|||
Drug Name |
PMID27539678-Compound-6
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ALMAC DISCOVERY LIMITED HARRISON, Timothy BURKAMP, Frank JORDAN, Linda BELL, Mark JANSSEN, Dominic MIEL, Hugues MCFARLAND, Mary
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H37N3O
|
|||
Canonical SMILES |
CC1(CCC(C2=C1C=CC(=C2)C3=NC(=CC=C3)N4CCN(CC4)CCCO)(C)C)C
|
|||
InChI |
1S/C26H37N3O/c1-25(2)11-12-26(3,4)22-19-20(9-10-21(22)25)23-7-5-8-24(27-23)29-16-14-28(15-17-29)13-6-18-30/h5,7-10,19,30H,6,11-18H2,1-4H3
|
|||
InChIKey |
ITCPVAVDRJPVOV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine kinase 1 (SPHK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Sphingosine kinase 1 (SPHK1) | Target's Patent Info | [1] | |
BioCyc | Sphingosine and sphingosine-1-phosphate metabolism | |||
KEGG Pathway | Sphingolipid metabolism | |||
Metabolic pathways | ||||
Calcium signaling pathway | ||||
Sphingolipid signaling pathway | ||||
VEGF signaling pathway | ||||
Fc gamma R-mediated phagocytosis | ||||
Tuberculosis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
TNFalpha Signaling Pathway | ||||
Panther Pathway | Angiogenesis | |||
VEGF signaling pathway | ||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
Beta3 integrin cell surface interactions | ||||
S1P1 pathway | ||||
Sphingosine 1-phosphate (S1P) pathway | ||||
PDGFR-beta signaling pathway | ||||
Reactome | Sphingolipid de novo biosynthesis | |||
VEGFR2 mediated cell proliferation | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Protein folding | ||||
Sphingolipid Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Sphingosine kinase inhibitors: a review of patent literature (2006-2015).Expert Opin Ther Pat. 2016 Dec;26(12):1409-1416. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.